Novel Ragweed Vaccine Shown to be Safe, Effective in the Long term for Mild to Severe Allergy
14th Nov 2006, 23:34 GMT
The most recent phase 2b trial data on Tolamba show that one 6-week course significantly relieved nasal symptoms through at least 2 allergy seasons; the mechanism of action needs to be further explored. Medscape Medical News Jennifer Holman
Novel Ragweed Vaccine Shown to be Safe, Effective in the Long term for Mild to Severe Allergy related news:
- New Rush Immunotherapy Protocol Is Safe and Effective — Medscape Allergy Headlines
- Isis Cholesterol Drug Shown Effective — Pharmaceuticals News from StratCenter.com
- Respiratory Symptoms Strongly Predict More Persistent Cow's Milk Allergy — Medscape Allergy Headlines
- Experts: Laser Eye Surgery Safe — RedOrbit News - Health
- Allergy And Immunology On The Cusp Of Major Breakthroughs — Health News from Medical News Today
- Novel drug-antidote combination shown safe in humans — EurekAlert! - Breaking News
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector — J Infect Dis Latest Issue
- Are you allergic to sex? — Blogging Baby
- Aleve Heart-Healthy Over Short-Term — iVillage Health & Well-Being News
- Volume 194, number 12: Is There a Safe Age for Vaccinating Infants with Tetravalent Rhesus-Human Reassortant Rotavirus Vaccine? — J Infect Dis Latest Issue